Genomics - AI trained on 9 trillion DNA letters predicts harmful mutations and designs new genomes
View as a Web Page
News Medical
 
  Genomics Genomics logo  
  The latest genomics news from News Medical  
 

Win the Diamond Award-Winning DS-11 FX+Win the Diamond Award-Winning DS-11 FX+

DeNovix is giving away a DS-11 FX+ Spectrophotometer / Fluorometer! This competition is being held to celebrate the instrument’s new Diamond Seal of Quality from SelectScience, achieved by receiving 500 product reviews. Entry is open to researchers around the world. See contest page to register and view details!

Register Now
 
   AI trained on 9 trillion DNA letters predicts harmful mutations and designs new genomesAI trained on 9 trillion DNA letters predicts harmful mutations and designs new genomes
 
Scientists developed Evo 2, a large biological foundation model trained on about 9 trillion DNA base pairs that can analyse genomic sequences across bacteria, plants, and humans. The model predicts functional effects of genetic variants and can generate genome-scale DNA sequences, enabling new approaches to studying and designing biological systems.
 
   How somatic mutations shape disease and reveal new drug targetsHow somatic mutations shape disease and reveal new drug targets
 
Researchers reviewed how somatic mutations accumulate in normal and diseased tissues, showing that natural selection can expand clones that influence disease risk, tissue adaptation, or cellular resilience. The study proposes somatic genomics as a powerful strategy to uncover disease mechanisms and identify new therapeutic targets across multiple conditions.
 
 FOXJ3 gene identified as the critical link between abnormal brain development and epilepsy
 
FOXJ3 gene identified as the critical link between abnormal brain development and epilepsyResearchers have discovered that mutations in the FOXJ3 gene act as a "master switch" failure, disrupting how the brain builds its layers and leading to FCD, a primary cause of drug-resistant epilepsy.
 
 
 DNA-based barcoding reveals which nanoparticles successfully deliver genetic therapies
 
DNA-based barcoding reveals which nanoparticles successfully deliver genetic therapiesDrug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to be within cells.
 
 
 FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancer
 
FOXJ1 gene may drive resistance to taxane chemotherapy in advanced prostate cancerA gene called FOXJ1 may drive resistance to taxane chemotherapy during treatment for advanced prostate cancer, according to a new study led by investigators at Weill Cornell Medicine and Beth Israel Deaconess Medical Center.
 
 
 Long-read whole genome sequencing uncovers new genetic variants linked to autism
 
Long-read whole genome sequencing uncovers new genetic variants linked to autismResearchers at the University of California San Diego have identified new genetic variants associated with autism spectrum disorder (ASD) by using long-read whole genome sequencing (LR-WGS), an emerging approach that reads large sections of the genome at once, making it easier for scientists to find new genetic variants and understand how genetic variants affect the function of a gene.
 
 
 Gene mutation that aids high-altitude survival could repair myelin sheath damage
 
Gene mutation that aids high-altitude survival could repair myelin sheath damageA genetic mutation that helps animals like yaks and Tibetan antelopes survive at high altitudes may hold the key to repairing nerve damage in conditions such as cerebral paralysis and multiple sclerosis (MS).
 
 
 Selfish chromosomes hijack Overdrive gene to eliminate rival sperm
 
Selfish chromosomes hijack Overdrive gene to eliminate rival spermA new University of Utah-led study has discovered the mechanism behind a decades-old evolutionary mystery-how "selfish chromosomes" cheat the rules of genetic inheritance.
 
 
 Genomic sequencing may expand newborn screening beyond biochemical tests
 
Genomic sequencing may expand newborn screening beyond biochemical testsRoutine newborn screening (NBS) has transformed early disease detection. However, traditional biochemical tests limit the range of conditions that can be identified at birth. Next-generation sequencing is being explored as a complementary screening tool.
 
 
 Study maps gene activity linked to neurotransmission in living brains
 
Study maps gene activity linked to neurotransmission in living brainsResearchers have identified a distinct and reproducible gene expression program associated with neurotransmission in the living human brain, offering unprecedented insight into the molecular mechanisms that support human cognition, emotion, and behavior.
 
 
 Tiny gene mutations shape cancer behavior and immune response
 
Tiny gene mutations shape cancer behavior and immune responseCancer is often thought of as a single disease. Yet even tumors that arise in the same organ can follow very different genetic paths.
 
 
 FDA approves first gene therapy for rare pediatric immune disorder
 
FDA approves first gene therapy for rare pediatric immune disorderDr. Donald Kohn has been developing gene therapies for rare pediatric immune disorders for over 30 years.
 
 
 How Diet Influences Gene Expression Through Epigenetic Mechanisms
 
How Diet Influences Gene Expression Through Epigenetic MechanismsThis article explains how diet creates sustained epigenetic changes that affect long-term health, disease risk, aging, and future environmental responses.
 
 
 Nabsys Showcases Genome-Scale Mapping of ORF2p DNA Nicking at AGBT 2026
 
Nabsys Showcases Genome-Scale Mapping of ORF2p DNA Nicking at AGBT 2026Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping (EGM) technology, today announced new findings presented at the Advances in Genome Biology and Technology (AGBT) 2026 meeting.
 
 

How would you rate today's newsletter?

 
             
 
 
Google News Icon Stay updated with the latest in health and medical news! Follow News‑Medical.net on Google News for real‑time updates. Click here to follow us now.
 
Facebook X Instagram LinkedIn Vimeo
Why did you receive this email?
You are receiving this email because you subscribed to updates from AZoNetwork UK Ltd. on one of our websites and requested to be notified of additional information.

Unsubscribe or Update Notification Preferences

Contact | About | Privacy Policy

- - - - - -

Registered Address:
AZoNetwork UK Ltd., NEO, 9 Charlotte St, Manchester, M1 4ET, UK

Manchester | Sydney | Boston

Copyright © 2000-2026